{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:03:27Z","timestamp":1792029807744,"version":"4.4.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:00:00Z","timestamp":1539043200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01131","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T01:52:35Z","timestamp":1539049955000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":119,"title":["Finerenone Attenuates Endothelial Dysfunction and Albuminuria in a Chronic Kidney Disease Model by a Reduction in Oxidative Stress"],"prefix":"10.3389","volume":"9","author":[{"given":"Raquel","family":"Gonz\u00e1lez-Bl\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Somoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gil-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Mart\u00edn Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ramiro-Cortijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Vega-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Miguel","family":"Ruilope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kolkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda S.","family":"Fern\u00e1ndez-Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"21876","DOI":"10.1074\/jbc.M115.657957","article-title":"Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of steroid receptor Coactivator-1.","volume":"290","author":"Amazit","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/jama.2015.10081","article-title":"Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial.","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/cmdc.201200081","article-title":"Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases.","volume":"7","author":"Barfacker","year":"2012","journal-title":"ChemMedChem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases.","volume":"65","author":"Bauersachs","year":"2015","journal-title":"Hypertension"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007004.pub3","article-title":"Aldosterone antagonists for preventing the progression of chronic kidney disease.","volume":"2014","author":"Bolignano","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000345243","article-title":"Vascular actions of aldosterone.","volume":"50","author":"Briet","year":"2013","journal-title":"J. Vasc. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.kint.2016.09.037","article-title":"Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.","volume":"91","author":"Carrero","year":"2017","journal-title":"Kidney Int."},{"key":"B8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00285287","article-title":"Albuminuria reflects widespread vascular damage. The Steno hypothesis.","volume":"32","author":"Deckert","year":"1989","journal-title":"Diabetologia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function.","volume":"82","author":"Droge","year":"2002","journal-title":"Physiol. Rev."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184888","article-title":"The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury.","volume":"12","author":"Dutzmann","year":"2017","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: from subspecialty to global health burden.","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1161\/01.ATV.0000133604.20182.cf","article-title":"Vascular protection: superoxide dismutase isoforms in the vessel wall.","volume":"24","author":"Faraci","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1046\/j.1523-1755.2000.00833.x","article-title":"Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure.","volume":"57","author":"Fogarty","year":"2000","journal-title":"Kidney Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1464-5491.2007.02361.x","article-title":"Genome-wide linkage scans for renal function and albuminuria in Type 2 diabetes mellitus: the Diabetes Heart Study.","volume":"25","author":"Freedman","year":"2008","journal-title":"Diabet. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/MNH.0b013e32833e4ce1","article-title":"Albuminuria: all you need to predict outcomes in chronic kidney disease?","volume":"19","author":"Gansevoort","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1111\/bph.13223","article-title":"Genetic predisposition to albuminuria is associated with increased arterial stiffness: role of elastin.","volume":"172","author":"Gil-Ortega","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1097\/01.ASN.0000036865.22253.D4","article-title":"Endothelial dilatory function predicts individual susceptibility to renal damage in the 5\/6 nephrectomized rat.","volume":"13","author":"Gschwend","year":"","journal-title":"J. Am. Soc. Nephrol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1523-1755.2002.00431.x","article-title":"Impaired coronary endothelial function in a rat model of spontaneous albuminuria.","volume":"62","author":"Gschwend","year":"","journal-title":"Kidney Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.lfs.2017.05.002","article-title":"Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: the aldosterone-mineralocorticoid receptor-Nox1 axis.","volume":"179","author":"Harvey","year":"2017","journal-title":"Life Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.freeradbiomed.2009.01.007","article-title":"Quantification of protein modification by oxidants.","volume":"46","author":"Hawkins","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/HJH.0b013e3282f50066","article-title":"Albuminuria, but not estimated glomerular filtration rate, is associated with maladaptive arterial remodeling: the Hoorn Study.","volume":"26","author":"Hermans","year":"2008","journal-title":"J. Hypertens."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1210\/en.2006-1157","article-title":"Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.","volume":"148","author":"Hirono","year":"2007","journal-title":"Endocrinology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0003-2697(76)90326-2","article-title":"A fluorometric method for determination of oxidized and reduced glutathione in tissues.","volume":"74","author":"Hissin","year":"1976","journal-title":"Anal. Biochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"F758","DOI":"10.1152\/ajprenal.00457.2007","article-title":"Glomerular hypertrophy precedes albuminuria and segmental loss of podoplanin in podocytes in Munich-Wistar-Fr\u00f6mter rats.","volume":"294","author":"Ijpelaar","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1159\/000237742","article-title":"Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.","volume":"30","author":"Khosla","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/FJC.0000000000000091","article-title":"Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury.","volume":"64","author":"Kolkhof","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/MNH.0000000000000147","article-title":"Nonsteroidal antagonists of the mineralocorticoid receptor.","volume":"24","author":"Kolkhof","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B28","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/HYPERTENSIONAHA.116.08526","article-title":"Nonsteroidal mineralocorticoid receptor antagonist finerenone protects against acute kidney injury-mediated chronic kidney disease: role of oxidative stress.","volume":"69","author":"Lattenist","year":"2017","journal-title":"Hypertension"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejim.2013.11.007","article-title":"Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review.","volume":"25","author":"Mavrakanas","year":"2014","journal-title":"Eur. J. Intern. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000350539","article-title":"Mineralocorticoid receptor blockade reduced oxidative stress in renal transplant recipients: a double-blind, randomized pilot study.","volume":"37","author":"Ojeda-Cervantes","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1046\/j.1440-1681.2003.03920.x","article-title":"Cerebral vascular effects of reactive oxygen species: recent evidence for a role of NADPH-oxidase.","volume":"30","author":"Paravicini","year":"2003","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1161\/HYPERTENSIONAHA.114.04273","article-title":"Prognostic value of microalbuminuria during antihypertensive treatment in essential hypertension.","volume":"64","author":"Pascual","year":"2014","journal-title":"Hypertension"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1093\/eurheartj\/eht187","article-title":"Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial.","volume":"34","author":"Pitt","year":"2013","journal-title":"Eur. Heart J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1161\/01.HYP.37.2.801","article-title":"Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension.","volume":"37","author":"Quaschning","year":"2001","journal-title":"Hypertension"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1097\/HJH.0000000000000292","article-title":"Development of albuminuria and enhancement of oxidative stress during chronic renin-angiotensin system suppression.","volume":"32","author":"Ruiz-Hurtado","year":"2014","journal-title":"J. Hypertens."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1089\/ars.2005.7.1294","article-title":"Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences.","volume":"7","author":"Sanz-Rosa","year":"2005","journal-title":"Antioxid. Redox. Signal."},{"key":"B39","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s10157-012-0646-y","article-title":"Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease.","volume":"16","author":"Satoh","year":"2012","journal-title":"Clin. Exp. Nephrol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/hr.2012.77","article-title":"Mapping genetic determinants of kidney damage in rat models.","volume":"35","author":"Schulz","year":"2012","journal-title":"Hypertens. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0003-2697(89)90192-9","article-title":"An assay for superoxide dismutase activity in mammalian tissue homogenates.","volume":"179","author":"Spitz","year":"1989","journal-title":"Anal. Biochem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1681\/ASN.2005121288","article-title":"Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms.","volume":"17","author":"Stehouwer","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1097\/HJH.0b013e3283642384","article-title":"Dissecting the genetic predisposition to albuminuria and endothelial dysfunction in a genetic rat model.","volume":"31","author":"Steireif","year":"2013","journal-title":"J. Hypertens."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-011-0242-4","article-title":"Increased cardiovascular risk in rats with primary renal dysfunction; mediating role for vascular endothelial function.","volume":"107","author":"Szymanski","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/eurheartj\/ehq254","article-title":"Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans.","volume":"32","author":"Thum","year":"2011","journal-title":"Eur. Heart J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000218062","article-title":"Proteinuria-associated endothelial dysfunction is strain dependent.","volume":"30","author":"Ulu","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/HYPERTENSIONAHA.111.170621","article-title":"Elimination of severe albuminuria in aging hypertensive rats by exchange of 2 chromosomes in double-consomic rats.","volume":"58","author":"van Es","year":"2011","journal-title":"Hypertension"},{"key":"B48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1161\/hy0102.100540","article-title":"Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency.","volume":"39","author":"Vaziri","year":"2002","journal-title":"Hypertension"},{"key":"B49","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress.","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"B50","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.coph.2012.12.007","article-title":"Mineralocorticoid receptor antagonists for therapy of coronary artery disease and related complications.","volume":"13","author":"Zwadlo","year":"2013","journal-title":"Curr. Opin. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T01:52:37Z","timestamp":1539049957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,9]]},"references-count":50,"alternative-id":["10.3389\/fphar.2018.01131"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01131","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,9]]},"article-number":"1131"}}